Erratum for

• Resting state functional brain connectivity in child and adolescent psychiatry: where are we now?

  Uddin LQ, Castellanos FX, Menon V. Uddin LQ, et al. Neuropsychopharmacology. 2024 Nov;50(1):196-200. doi: 10.1038/s41386-024-01888-1. Epub 2024 May 22. Neuropsychopharmacology. 2024. PMID: 38778158 Free PMC article. Review.
• NIMH perspectives on future directions in neuroimaging for mental health.

  Wijtenburg SA, Rowland LM, Vicentic A, Rossi AF, Brady LS, Gordon JA, Lisanby SH. Wijtenburg SA, et al. Neuropsychopharmacology. 2024 Nov;50(1):294-297. doi: 10.1038/s41386-024-01900-8. Epub 2024 Jun 19. Neuropsychopharmacology. 2024. PMID: 38898207 Free PMC article. Review.
• Quality over quantity: powering neuroimaging samples in psychiatry.

  Makowski C, Nichols TE, Dale AM. Makowski C, et al. Neuropsychopharmacology. 2024 Nov;50(1):58-66. doi: 10.1038/s41386-024-01893-4. Epub 2024 Jun 20. Neuropsychopharmacology. 2024. PMID: 38902353 Review.
• Racial and ethnic socioenvironmental inequity and neuroimaging in psychiatry: a brief review of the past and recommendations for the future.

  Harnett NG, Merrill LC, Fani N. Harnett NG, et al. Neuropsychopharmacology. 2024 Nov;50(1):3-15. doi: 10.1038/s41386-024-01901-7. Epub 2024 Jun 20. Neuropsychopharmacology. 2024. PMID: 38902354 Review.
• A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response.

  Al-Sharif NB, Zavaliangos-Petropulu A, Narr KL. Al-Sharif NB, et al. Neuropsychopharmacology. 2024 Nov;50(1):211-229. doi: 10.1038/s41386-024-01894-3. Epub 2024 Jun 20. Neuropsychopharmacology. 2024. PMID: 38902355 Review.
• Applications of functional neurotransmitter release imaging with genetically encoded sensors in psychiatric research.

  Wright EC, Scott E, Tian L. Wright EC, et al. Neuropsychopharmacology. 2024 Nov;50(1):269-273. doi: 10.1038/s41386-024-01903-5. Epub 2024 Jun 28. Neuropsychopharmacology. 2024. PMID: 38942957 Free PMC article. Review.
• Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression.

  Prompiengchai S, Dunlop K. Prompiengchai S, et al. Neuropsychopharmacology. 2024 Nov;50(1):230-245. doi: 10.1038/s41386-024-01907-1. Epub 2024 Jul 1. Neuropsychopharmacology. 2024. PMID: 38951585 Review.
• Advancement in human neuroimaging based on proximity ligation assay in brain disease.

  Borroto-Escuela DO, Fuxe K. Borroto-Escuela DO, et al. Neuropsychopharmacology. 2024 Nov;50(1):326-327. doi: 10.1038/s41386-024-01911-5. Neuropsychopharmacology. 2024. PMID: 38956177 No abstract available.
• Brain-based graph-theoretical predictive modeling: a novel approach to prospectively map psychiatric symptoms.

  Dan R, Pizzagalli DA. Dan R, et al. Neuropsychopharmacology. 2024 Nov;50(1):322-323. doi: 10.1038/s41386-024-01924-0. Neuropsychopharmacology. 2024. PMID: 39014122 No abstract available.
• Virtual reality exposure therapy advances and potential for clinical and experimental use.

  Rothbaum BO, Rothbaum JO. Rothbaum BO, et al. Neuropsychopharmacology. 2024 Nov;50(1):343-344. doi: 10.1038/s41386-024-01930-2. Neuropsychopharmacology. 2024. PMID: 39020139 No abstract available.
• Pump the brakes: identifying neurobiological targets to enhance inhibitory control in drug addiction.

  Ceceli AO, Goldstein RZ. Ceceli AO, et al. Neuropsychopharmacology. 2024 Nov;50(1):330-331. doi: 10.1038/s41386-024-01928-w. Neuropsychopharmacology. 2024. PMID: 39020140 No abstract available.
• Rewiring the brain: Inflammation's impact on glutamate and neural networks in depression.

  Haroon E, Miller AH. Haroon E, et al. Neuropsychopharmacology. 2024 Nov;50(1):312-313. doi: 10.1038/s41386-024-01921-3. Neuropsychopharmacology. 2024. PMID: 39020141 No abstract available.
• Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics.

  Gaggi NL, Iosifescu DV. Gaggi NL, et al. Neuropsychopharmacology. 2024 Nov;50(1):314-315. doi: 10.1038/s41386-024-01929-9. Neuropsychopharmacology. 2024. PMID: 39025949 No abstract available.
• Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity.

  Barone JC, Eisenlohr-Moul TA. Barone JC, et al. Neuropsychopharmacology. 2024 Nov;50(1):353-354. doi: 10.1038/s41386-024-01931-1. Neuropsychopharmacology. 2024. PMID: 39025950 No abstract available.
• Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy.

  Smucny J, Carter CS. Smucny J, et al. Neuropsychopharmacology. 2024 Nov;50(1):341-342. doi: 10.1038/s41386-024-01932-0. Neuropsychopharmacology. 2024. PMID: 39025951 No abstract available.
• Neuroimaging education in psychiatric training.

  Cooper JJ, Valencia VA, Niu K. Cooper JJ, et al. Neuropsychopharmacology. 2024 Nov;50(1):298-304. doi: 10.1038/s41386-024-01909-z. Epub 2024 Jul 18. Neuropsychopharmacology. 2024. PMID: 39025952 Review.
• Environmental and neurodevelopmental contributors to youth mental illness.

  Whittle S, Zhang L, Rakesh D. Whittle S, et al. Neuropsychopharmacology. 2024 Nov;50(1):201-210. doi: 10.1038/s41386-024-01926-y. Epub 2024 Jul 19. Neuropsychopharmacology. 2024. PMID: 39030435 Free PMC article. Review.
• Pons connectivity correlates with neurophysiological and clinical signatures of predictive coding in psychosis.

  Abram SV, Hua JPY. Abram SV, et al. Neuropsychopharmacology. 2024 Nov;50(1):351-352. doi: 10.1038/s41386-024-01919-x. Neuropsychopharmacology. 2024. PMID: 39039138 No abstract available.
• Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.

  Asch RH, Abdallah CG, Carson RE, Esterlis I. Asch RH, et al. Neuropsychopharmacology. 2024 Nov;50(1):153-163. doi: 10.1038/s41386-024-01913-3. Epub 2024 Jul 22. Neuropsychopharmacology. 2024. PMID: 39039139 Review.
• Neuroimaging for precision medicine in psychiatry.

  Williams LM, Whitfield Gabrieli S. Williams LM, et al. Neuropsychopharmacology. 2024 Nov;50(1):246-257. doi: 10.1038/s41386-024-01917-z. Epub 2024 Jul 22. Neuropsychopharmacology. 2024. PMID: 39039140 Review.
• Neuroimaging and suicide-specific stimuli.

  Ballard ED, Lamontagne SJ. Ballard ED, et al. Neuropsychopharmacology. 2024 Nov;50(1):308-309. doi: 10.1038/s41386-024-01936-w. Neuropsychopharmacology. 2024. PMID: 39048653 No abstract available.
• A novel fluorescently labelled ligand for the detection of DAT in immune cells by flow cytometry.

  Camacho-Hernandez GA, Newman AH. Camacho-Hernandez GA, et al. Neuropsychopharmacology. 2024 Nov;50(1):349-350. doi: 10.1038/s41386-024-01935-x. Neuropsychopharmacology. 2024. PMID: 39048654 No abstract available.
• Human neuroimaging and antipsychotic neurobiology at millisecond temporal resolution.

  Eisenberg DP, Berman KF. Eisenberg DP, et al. Neuropsychopharmacology. 2024 Nov;50(1):306-307. doi: 10.1038/s41386-024-01933-z. Neuropsychopharmacology. 2024. PMID: 39060437 No abstract available.
• The promise of precision functional mapping for neuroimaging in psychiatry.

  Demeter DV, Greene DJ. Demeter DV, et al. Neuropsychopharmacology. 2024 Nov;50(1):16-28. doi: 10.1038/s41386-024-01941-z. Epub 2024 Jul 31. Neuropsychopharmacology. 2024. PMID: 39085426 Review.
• Therapeutic effects of extinction require hippocampal input and BDNF signaling in IL.

  Paredes D, Morilak DA. Paredes D, et al. Neuropsychopharmacology. 2024 Nov;50(1):355-356. doi: 10.1038/s41386-024-01948-6. Neuropsychopharmacology. 2024. PMID: 39085427 No abstract available.
• Developmental neuroplasticity and adversity-related risk for psychopathology.

  Sisk LM, Gee DG. Sisk LM, et al. Neuropsychopharmacology. 2024 Nov;50(1):316-317. doi: 10.1038/s41386-024-01950-y. Neuropsychopharmacology. 2024. PMID: 39095522 No abstract available.
• Representational similarity analysis of neural patterns in childhood maltreatment.

  Del Motte MG, Tamman AJF. Del Motte MG, et al. Neuropsychopharmacology. 2024 Nov;50(1):357-358. doi: 10.1038/s41386-024-01955-7. Neuropsychopharmacology. 2024. PMID: 39097622 No abstract available.
• Precision functional mapping for target engagement in drug development.

  Siegel JS. Siegel JS. Neuropsychopharmacology. 2024 Nov;50(1):339-340. doi: 10.1038/s41386-024-01945-9. Neuropsychopharmacology. 2024. PMID: 39103494 No abstract available.
• Measuring neuroplasticity in human development: the potential to inform the type and timing of mental health interventions.

  Herzberg MP, Nielsen AN, Luby J, Sylvester CM. Herzberg MP, et al. Neuropsychopharmacology. 2024 Nov;50(1):124-136. doi: 10.1038/s41386-024-01947-7. Epub 2024 Aug 5. Neuropsychopharmacology. 2024. PMID: 39103496 Review.
• Opioid inhalation in mice as a model to investigate biological drivers of the opioid crisis.

  Marchette RCN, Vendruscolo LF. Marchette RCN, et al. Neuropsychopharmacology. 2024 Nov;50(1):347-348. doi: 10.1038/s41386-024-01949-5. Neuropsychopharmacology. 2024. PMID: 39103497 No abstract available.
• Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology.

  Heller NH, Barrett FS. Heller NH, et al. Neuropsychopharmacology. 2024 Nov;50(1):324-325. doi: 10.1038/s41386-024-01954-8. Neuropsychopharmacology. 2024. PMID: 39107542 No abstract available.
• Leveraging large-scale brain networks in rats to understand neurological and psychiatric disorders in humans.

  Lu H, Yang Y. Lu H, et al. Neuropsychopharmacology. 2024 Nov;50(1):337-338. doi: 10.1038/s41386-024-01952-w. Neuropsychopharmacology. 2024. PMID: 39117899 No abstract available.
• Multisystem stress response biotypes: a precision psychiatry approach to identifying and treating multidimensional risk factors for anhedonia in adolescence.

  Roubinov DS, Belger A. Roubinov DS, et al. Neuropsychopharmacology. 2024 Nov;50(1):318-319. doi: 10.1038/s41386-024-01953-9. Neuropsychopharmacology. 2024. PMID: 39117900 No abstract available.
• Applying fetal, infant, and toddler (FIT) neuroimaging to understand mental health.

  Spann MN, Scheinost D. Spann MN, et al. Neuropsychopharmacology. 2024 Nov;50(1):310-311. doi: 10.1038/s41386-024-01957-5. Neuropsychopharmacology. 2024. PMID: 39117902 No abstract available.
• Current best practices and future opportunities for reproducible findings using large-scale neuroimaging in psychiatry.

  Jahanshad N, Lenzini P, Bijsterbosch J. Jahanshad N, et al. Neuropsychopharmacology. 2024 Nov;50(1):37-51. doi: 10.1038/s41386-024-01938-8. Epub 2024 Aug 8. Neuropsychopharmacology. 2024. PMID: 39117903 Free PMC article. Review.
• Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging.

  Gergues MM, Lalani LK, Kheirbek MA. Gergues MM, et al. Neuropsychopharmacology. 2024 Nov;50(1):274-284. doi: 10.1038/s41386-024-01942-y. Epub 2024 Aug 9. Neuropsychopharmacology. 2024. PMID: 39122815 Review.
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.

  Howes O, Marcinkowska J, Turkheimer FE, Carr R. Howes O, et al. Neuropsychopharmacology. 2024 Nov;50(1):164-183. doi: 10.1038/s41386-024-01943-x. Epub 2024 Aug 12. Neuropsychopharmacology. 2024. PMID: 39134769 Free PMC article. Review.
• Psychiatric neuroimaging designs for individualised, cohort, and population studies.

  Gell M, Noble S, Laumann TO, Nelson SM, Tervo-Clemmens B. Gell M, et al. Neuropsychopharmacology. 2024 Nov;50(1):29-36. doi: 10.1038/s41386-024-01918-y. Epub 2024 Aug 14. Neuropsychopharmacology. 2024. PMID: 39143320 Free PMC article. Review.
• Harnessing mega-analysis in the era of "big data" neuroimaging.

  Norman LJ, Shaw P. Norman LJ, et al. Neuropsychopharmacology. 2024 Nov;50(1):332-334. doi: 10.1038/s41386-024-01964-6. Neuropsychopharmacology. 2024. PMID: 39143321 No abstract available.
• Connectome-based fingerprinting: reproducibility, precision, and behavioral prediction.

  Ramduny J, Kelly C. Ramduny J, et al. Neuropsychopharmacology. 2024 Nov;50(1):114-123. doi: 10.1038/s41386-024-01962-8. Epub 2024 Aug 15. Neuropsychopharmacology. 2024. PMID: 39147868 Review.
• Democratizing technologies in psychiatry: non-human primate neuroanatomy paves the way for accessible neurofeedback in the wild.

  Trambaiolli LR, Feusner JD. Trambaiolli LR, et al. Neuropsychopharmacology. 2024 Nov;50(1):328-329. doi: 10.1038/s41386-024-01968-2. Neuropsychopharmacology. 2024. PMID: 39147869 No abstract available.
• Distributed circuits regulating defensive state transitions: freezing, flight and fight.

  Borkar CD, Fadok JP. Borkar CD, et al. Neuropsychopharmacology. 2024 Nov;50(1):320-321. doi: 10.1038/s41386-024-01965-5. Neuropsychopharmacology. 2024. PMID: 39152220 No abstract available.
• Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry.

  Wengler K, Trujillo P, Cassidy CM, Horga G. Wengler K, et al. Neuropsychopharmacology. 2024 Nov;50(1):137-152. doi: 10.1038/s41386-024-01934-y. Epub 2024 Aug 19. Neuropsychopharmacology. 2024. PMID: 39160355 Review.
• Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers.

  Houghton DC, Spratt HM. Houghton DC, et al. Neuropsychopharmacology. 2024 Nov;50(1):345-346. doi: 10.1038/s41386-024-01969-1. Neuropsychopharmacology. 2024. PMID: 39169212 No abstract available.
• Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective.

  Etkin A, Powell J, Savitz AJ. Etkin A, et al. Neuropsychopharmacology. 2024 Nov;50(1):258-268. doi: 10.1038/s41386-024-01970-8. Epub 2024 Aug 21. Neuropsychopharmacology. 2024. PMID: 39169213 Free PMC article. Review.
• What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?

  Fujimoto S, Fujimoto A, Elorette C, Choi KS, Mayberg H, Russ B, Rudebeck P. Fujimoto S, et al. Neuropsychopharmacology. 2024 Nov;50(1):184-195. doi: 10.1038/s41386-024-01976-2. Epub 2024 Aug 28. Neuropsychopharmacology. 2024. PMID: 39198580 Review.
• Replicability and generalizability in population psychiatric neuroimaging.

  Marek S, Laumann TO. Marek S, et al. Neuropsychopharmacology. 2024 Nov;50(1):52-57. doi: 10.1038/s41386-024-01960-w. Epub 2024 Aug 30. Neuropsychopharmacology. 2024. PMID: 39215207 Free PMC article. Review.
• Revisiting the role of computational neuroimaging in the era of integrative neuroscience.

  Loosen AM, Kato A, Gu X. Loosen AM, et al. Neuropsychopharmacology. 2024 Nov;50(1):103-113. doi: 10.1038/s41386-024-01946-8. Epub 2024 Sep 6. Neuropsychopharmacology. 2024. PMID: 39242921 Free PMC article. Review.
• Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility.

  Ekhtiari H, Zare-Bidoky M, Sangchooli A, Valyan A, Abi-Dargham A, Cannon DM, Carter CS, Garavan H, George TP, Ghobadi-Azbari P, Juchem C, Krystal JH, Nichols TE, Öngür D, Pernet CR, Poldrack RA, Thompson PM, Paulus MP. Ekhtiari H, et al. Neuropsychopharmacology. 2024 Nov;50(1):67-84. doi: 10.1038/s41386-024-01973-5. Epub 2024 Sep 6. Neuropsychopharmacology. 2024. PMID: 39242922 Review.
• Leveraging ultra-high field (7T) MRI in psychiatric research.

  Calabro FJ, Parr AC, Sydnor VJ, Hetherington H, Prasad KM, Ibrahim TS, Sarpal DK, Famalette A, Verma P, Luna B. Calabro FJ, et al. Neuropsychopharmacology. 2024 Nov;50(1):85-102. doi: 10.1038/s41386-024-01980-6. Epub 2024 Sep 9. Neuropsychopharmacology. 2024. PMID: 39251774 Review.
• Correction: Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging.

  Gergues MM, Lalani LK, Kheirbek MA. Gergues MM, et al. Neuropsychopharmacology. 2024 Nov;50(1):305. doi: 10.1038/s41386-024-01982-4. Neuropsychopharmacology. 2024. PMID: 39251775 Free PMC article. No abstract available.
• The might of light for revealing neuropsychiatric mechanisms.

  Kaya K, Blumberg HP. Kaya K, et al. Neuropsychopharmacology. 2024 Nov;50(1):335-336. doi: 10.1038/s41386-024-01974-4. Neuropsychopharmacology. 2024. PMID: 39266652 Free PMC article. No abstract available.
• Memory engram stability and flexibility.

  Zaki Y, Cai DJ. Zaki Y, et al. Neuropsychopharmacology. 2024 Nov;50(1):285-293. doi: 10.1038/s41386-024-01979-z. Epub 2024 Sep 18. Neuropsychopharmacology. 2024. PMID: 39300271 Free PMC article. Review.
• Neuroimaging in psychiatry: toward mechanistic insights and clinical utility.

  Barch D, Liston C. Barch D, et al. Neuropsychopharmacology. 2024 Nov;50(1):1-2. doi: 10.1038/s41386-024-01984-2. Epub 2024 Oct 11. Neuropsychopharmacology. 2024. PMID: 39394256 No abstract available.